abstract |
A subtype of a humanized PM-1 antibody directed against the interleukin-6 receptor (IL-6R), wherein the heavy chain C-terminus is Pro-NH2 (447), an antibody subtype (1), and an interleukin-6 receptor (IL-6R) A subtype of a humanized PM-1 antibody against the leukin-6 receptor (IL-6R), wherein both heavy chain C-termini are Pro-NH2 (447), as well as antibody subtype (2), and A pharmaceutical composition comprising. |